Loading...
Loading...
HUTCHMED (China) Ltd
HUTCHMED (China) Ltd. Spoken Alpha tracks HMDCF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks HMDCF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for HMDCF.
curl https://api.spokenalpha.com/v1/companies/HMDCF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.57 | $1.86 | -15.7% | -6.8% | -7.5% |
| Q4 FY2026 | $1.74 | $1.81 | -4.1% | -9.0% | -8.8% |
| Q3 FY2026 | $1.53 | $1.67 | -8.5% | +1.8% | +4.6% |
| Q2 FY2026 | $1.72 | $1.76 | -2.3% | +0.2% | +2.2% |
| Q1 FY2025 | $1.43 | $1.73 | -17.3% | -2.3% | -0.5% |
| Q4 FY2025 | $1.84 | $1.89 | -2.4% | -2.4% | -2.0% |
| Q3 FY2025 | $1.47 | $1.77 | -16.9% | -5.1% | -6.4% |
| Q2 FY2025 | $1.64 | $1.93 | -14.8% | -6.8% | -4.6% |
| Q1 FY2024 | $1.77 | $1.94 | -9.0% | +1.9% | +3.0% |
| Q4 FY2024 | $1.84 | $2.00 | -8.1% | 0.0% | +1.2% |